🔎 Trials Near Me

Home › Obesità › Florida

Studi clinici su Obesità nello stato di Florida

74 studi su Obesità cercano partecipanti presso sedi nello stato di Florida.

Città nello stato di Florida

Testo ufficiale dello studio (inglese)

Comparing the Efficacy and Safety of the EndoZip System and Apollo ESG in Obese Patients

  • Orlando Health, Inc., Orlando
In reclutamento
Età da 21 a 65 · Tutti i sessi · Aggiornato il 1 ott 2026 · NCT07090005

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

  • Innovative Research of West Florida /ID# 281963, Clearwater
  • Encore Research Group-Jacksonville Center for Clinical Research /ID# 282740, Jacksonville
  • Altus Clinical Research - Lake Worth - South Congress Avenue /ID# 281979, Lake Worth
  • e altri 8
In reclutamentoFase 2
Età da 18 a 75 · Tutti i sessi · Aggiornato il 1 ott 2026 · NCT07752979

A Study to Evaluate the Impact of Renal Impairment on the Pharmacokinetics (PK) of Ribupatide

  • Kailera Clinical Site, Orlando
In reclutamentoFase 1Volontari sani benvenuti
Età da 18 a 85 · Tutti i sessi · Aggiornato il 1 ott 2026 · NCT07793929

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

  • Northeast Research Institute, Fleming Island
  • Jacksonville Ctr Clin Res, Jacksonville
  • Florida Institute for Clinical Research, LLC, Orlando
  • e altri 1
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 30 set 2026 · NCT07533175

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

  • Encore Medical Research LLC, Hollywood
  • Jacksonville Ctr for Clin Res, Jacksonville
  • Encore Medical Research of Weston, Weston
In reclutamentoFase 3
Età da 8 a 18 · Tutti i sessi · Aggiornato il 30 set 2026 · NCT07253285

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

  • Omega Research Orlando, Altamonte Springs
  • American Research Institute, Cutler Bay
  • K2 Medical Research - Maitland, Maitland
  • e altri 1
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 30 set 2026 · NCT07783802

Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes

  • AMR Clinical - Miami, Doral
  • AMR Clinical - Fort Myers, Fort Myers
  • AGA Clinical Trials, Hialeah
  • e altri 6
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 29 set 2026 · NCT07685808

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

  • Brain Matters Research, Delray Beach
  • Northeast Research Institute, Fleming Island
  • Miguel Rebollar PA, Hialeah
  • e altri 5
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 28 set 2026 · NCT07720271

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

  • Encore Medical Research LLC, Hollywood
  • NextPhase Research, Hollywood
  • Jacksonville Ctr Clin Res, Jacksonville
  • e altri 7
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 28 set 2026 · NCT07668414

Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss

  • Clinical Neuroscience Solutions, Orlando
In reclutamentoFase 2
Età da 18 a 75 · Tutti i sessi · Aggiornato il 28 set 2026 · NCT07837973

Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D

  • Clinical Pharmacology of Miami, Miami
In reclutamentoFase 1
Età da 18 a 65 · Tutti i sessi · Aggiornato il 28 set 2026 · NCT07399678

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

  • Nature Coast Clinical Research, Crystal River
  • West Coast Eye Institute, Lecanto
  • South Broward Research, Miramar
  • e altri 3
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 28 set 2026 · NCT07595549

A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus

  • Research Site, Jacksonville
  • Research Site, Jacksonville
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT07776509

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

  • William A. Shands Hospital at the University of Florida, Gainesville
  • Florida Hospital- Center for Pediatric Research, Orlando
  • Nemours Children's Health, Orlando
  • e altri 1
In reclutamentoFase 3
Età da 6 a 17 · Tutti i sessi · Aggiornato il 24 set 2026 · NCT06672549

AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight

  • South Broward Research LLC, Miramar
  • Clinical Neuroscience Solution, Orlando
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 24 set 2026 · NCT07339423

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

  • Research Associates of South Florida - Miami - Southwest 8th Street, Miami
  • Gastro Health Research - Miami, Miami
  • Orlando Health, Orlando
  • e altri 3
In reclutamentoFase 3
Età da 18 a 70 · Tutti i sessi · Aggiornato il 24 set 2026 · NCT06937099

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

  • Research Associates of South Florida - Miami - Southwest 8th Street, Miami
  • Gastro Health Research - Miami, Miami
  • Orlando Health, Orlando
  • e altri 3
In reclutamentoFase 3
Età da 18 a 70 · Tutti i sessi · Aggiornato il 24 set 2026 · NCT06937086

A Study of Tirzepatide (LY3298176) in Participants With Type 1 Diabetes Mellitus and Overweight or Obesity

  • Clinical Pharmacology of Miami, Miami
In reclutamentoFase 1
Età da 18 a 70 · Tutti i sessi · Aggiornato il 23 set 2026 · NCT07803744

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

  • JEM Research Institute, Atlantis
  • BioMed Research & Medical Center, Miami
  • Adult Medicine of Lake County, Inc., Mt. Dora
  • e altri 3
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07321886

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

  • Excel Medical Clinical Trials, Boca Raton
  • Velocity Clinical Research - New Smyrna Beach, Edgewater
  • Alliance for Multispecialty Research - Fort Myers, Fort Myers
  • e altri 20
In reclutamentoFase 3
Età da 45 a 99 · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07037433

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

  • JEM Research Institute, Atlantis
  • AMR Clinical, Doral
  • Northeast Research Institute (NERI), Fleming Island
  • e altri 4
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07392190

A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

  • Flourish Research - Miami, LLC, Miami
  • PharmaDev Clinical Research Institute, LLC, Miami
  • Emerald Coast Neurology - Airport Boulevard, Pensacola
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07369011

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

  • New Horizon Research Center, Miami
  • Indago Research & Health Center, Inc, Miami Lakes
  • Suncoast Clinical Research, Inc., New Port Richey
  • e altri 2
In reclutamentoFase 2
Età da 18 a 75 · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07589608

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

  • Westside Center for Clinical Research, Jacksonville
  • Care Access - St. Petersburg, St. Petersburg
  • Conquest Research, Winter Park
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07353931

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

  • Arrow Clinical Trials, Daytona Beach
  • Care Access - Delray Beach, Delray Beach
  • Fleming Island Center for Clinical Research, Fleming Island
  • e altri 7
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07282600

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

  • Research Site, Coral Gables
  • Research Site, Fleming Island
  • Research Site, Fort Lauderdale
  • e altri 1
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07784270

Effects of Glucagon-like Peptide-1 (GLP-1) Agonist in Neuro-reproductive Function in Obese Adolescent Females With Polycystic Ovary Syndrome (PCOS)

  • Nemours Children's Clinic, Jacksonville
In reclutamentoStudio osservazionale
Età da 12 a 18 · Donne · Aggiornato il 18 set 2026 · NCT07169136

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

  • Orlando Heart and Vascular Institute, Altamonte Springs
  • D and H Tamarac Research Center, Aventura
  • Excel Medical Clinical Trials, Boca Raton
  • e altri 18
In reclutamentoFase 3
Età da 18 a 99 · Tutti i sessi · Aggiornato il 16 set 2026 · NCT07037459

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

  • AURORA-1 Clinical Site, Boca Raton
  • AURORA-1 Clinical Site, Daytona Beach
  • AURORA-1 Clinical Site, Jacksonville
  • e altri 6
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 16 set 2026 · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

  • AURORA-2 Clinical Site, Boca Raton
  • AURORA-2 Clinical Site, Daytona Beach
  • AURORA-2 Clinical Site, Jacksonville
  • e altri 6
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 16 set 2026 · NCT07743450

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

  • Tampa Bay Medical Research, Inc., Clearwater
  • Center for Diabetes, Obesity and Metabolism Inc, Pembroke Pines
  • Progressive Medical Research, Port Orange
  • e altri 1
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 14 set 2026 · NCT07351058

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

  • Renstar Medical Research, Ocala
  • Oviedo Medical Research, Oviedo
In reclutamentoFase 2
Età da 18 a 75 · Tutti i sessi · Aggiornato il 14 set 2026 · NCT06897475

Feasibility and Acceptability of a Pediatric Referral to Summer Day Camps to Treat Obesity in Children From Low-Income Households

  • University of Central Florida, Orlando
In reclutamento
Età da 5 a 11 · Tutti i sessi · Aggiornato il 14 set 2026 · NCT07464015

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

  • ACCOMPLISH-2 Research Site, Clearwater
  • ACCOMPLISH-2 Research Site, Fort Myers
  • ACCOMPLISH-2 Research Site, Jacksonville
  • e altri 5
In reclutamentoFase 3Volontari sani benvenuti
Età da 18 a 79 · Tutti i sessi · Aggiornato il 11 set 2026 · NCT07654374

AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

  • PharmaDev Clinical Research Institute LLC, Miami
  • Essence MD Research, Naples
  • Renstar Medical Research, Ocala
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 11 set 2026 · NCT07571005

Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight

  • ERG Holding Company, LLC / Evolution Research Group, LLC, Delray Beach
  • ERG Holding Company, LLC / Evolution Research Group, LLC, Fort Myers
  • Jedidiah Clinical Research, Tampa
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 9 set 2026 · NCT07770841

AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

  • DM Clinical, Bradenton
  • Essence MD Research, Naples
  • Palm Beach Research Center, West Palm Beach
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 9 set 2026 · NCT07571109

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

  • Precision Clinical Research, Sunrise
In reclutamentoFase 2
Età da 18 a 75 · Tutti i sessi · Aggiornato il 8 set 2026 · NCT07215559

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

  • New Horizon Research Center, Miami
  • Indago Research & Health Center, Inc, Miami Lakes
  • Suncoast Clinical Research, Inc., New Port Richey
  • e altri 2
In reclutamentoFase 2
Età da 18 a 75 · Tutti i sessi · Aggiornato il 8 set 2026 · NCT06143956

Fonte: ClinicalTrials.gov, dati recuperati il 2 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.